Xiaoteng Ma

1.8k total citations · 3 hit papers
66 papers, 1.0k citations indexed

About

Xiaoteng Ma is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xiaoteng Ma has authored 66 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 25 papers in Surgery and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xiaoteng Ma's work include Acute Myocardial Infarction Research (22 papers), Cardiac Imaging and Diagnostics (15 papers) and Coronary Interventions and Diagnostics (13 papers). Xiaoteng Ma is often cited by papers focused on Acute Myocardial Infarction Research (22 papers), Cardiac Imaging and Diagnostics (15 papers) and Coronary Interventions and Diagnostics (13 papers). Xiaoteng Ma collaborates with scholars based in China, United States and United Kingdom. Xiaoteng Ma's co-authors include Fei Gao, Yuxuan Guo, Congting Guo, Yujie Zhou, Qiaoyu Shao, Zhijian Wang, Hua Shen, Yujing Cheng, Zhijian Wang and Lixia Yang and has published in prestigious journals such as Scientific Reports, The American Journal of Cardiology and Journal of the American Geriatrics Society.

In The Last Decade

Xiaoteng Ma

59 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Off-target effects in CRISPR/Cas9 gene editing

2023 285 citations Congting Guo, Xiaoteng Ma et al. Frontiers in Bioengineering and Biotechnology profile →
Prognostic Impact of Multiple Lymphocyte-Based Inflammatory Indices in Acute Coronary Syndrome Patients

2022 97 citations Xiaoteng Ma, Qiaoyu Shao et al. Frontiers in Cardiovascular Medicine profile →
ONOO–-activatable and LD-traced NIR fluorescent probe for mechanism study and early diagnosis of NAFLD and diabetes induced liver injury

2024 44 citations Jiamin Wang, Ruiqi Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoteng Ma China	14	374	297	180	177	176	66	1.0k
Yasuyuki Kawai Japan	19	241 0.6×	297 1.0×	69 0.4×	93 0.5×	151 0.9×	58	895
Zihua Zhou China	18	278 0.7×	315 1.1×	89 0.5×	107 0.6×	109 0.6×	64	1.1k
Shi Tai China	17	202 0.5×	214 0.7×	55 0.3×	152 0.9×	177 1.0×	53	837
Heng Ge China	17	315 0.8×	356 1.2×	108 0.6×	79 0.4×	52 0.3×	54	928
Naoki Watanabe Japan	18	573 1.5×	463 1.6×	168 0.9×	71 0.4×	59 0.3×	67	1.4k
Tatsuo Iiyama Japan	16	202 0.5×	238 0.8×	286 1.6×	133 0.8×	67 0.4×	48	1.0k
Katherine E. Harris United States	20	1.1k 3.0×	217 0.7×	204 1.1×	60 0.3×	319 1.8×	35	1.7k
Andreea C. Popescu Romania	16	363 1.0×	689 2.3×	66 0.4×	85 0.5×	43 0.2×	40	1.2k
Joji Nitobe Japan	21	815 2.2×	366 1.2×	76 0.4×	167 0.9×	87 0.5×	46	1.4k

Countries citing papers authored by Xiaoteng Ma

Since Specialization

Citations

This map shows the geographic impact of Xiaoteng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoteng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoteng Ma more than expected).

Fields of papers citing papers by Xiaoteng Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoteng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoteng Ma. The network helps show where Xiaoteng Ma may publish in the future.

Co-authorship network of co-authors of Xiaoteng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoteng Ma. A scholar is included among the top collaborators of Xiaoteng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoteng Ma. Xiaoteng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Xiaoteng, et al.. (2025). Rationale and Design of the EPISODE Trial: A Randomized Controlled Trial on the Effect of PCSK9 Inhibitors in Calcific Aortic Valve Stenosis. Journal of the American Heart Association. 14(19). e042112–e042112. 1 indexed citations

Gao, Fei, et al.. (2025). In‐Hospital Outcomes in Patients With Acute Myocardial Infarction and No Standard Modifiable Cardiovascular Risk Factors Across Varying Body Mass Index: Findings From the CCC‐ACS Project. Journal of the American Heart Association. 14(7). e037651–e037651. 2 indexed citations

Ma, Xiaoteng, Yan Sun, Yujing Cheng, et al.. (2025). Effect of hyperhomocysteinemia on the prognostic value of triglyceride glucose index in patients with acute coronary syndrome. Frontiers in Cardiovascular Medicine. 11. 1517437–1517437. 1 indexed citations

Han, Ruiqi, Xiaoteng Ma, Lingli Wang, et al.. (2025). ONOO−-activated deep NIR-I fluorescent probe for visualization of non-alcoholic fatty liver disease. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 348(Pt 2). 127097–127097.

Peng, Yulu, et al.. (2024). The impact of female sex hormones on cardiovascular disease: from mechanisms to hormone therapy. Journal of Geriatric Cardiology. 21(6). 669–681. 6 indexed citations

Ma, Xiaoteng, et al.. (2024). Potential Mechanisms of Epicardial Adipose Tissue Influencing Heart Failure with Preserved Ejection Fraction. Reviews in Cardiovascular Medicine. 25(9). 311–311. 4 indexed citations

Zhang, Xiaoming, et al.. (2024). Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors. Diabetology & Metabolic Syndrome. 16(1). 278–278. 1 indexed citations

Han, Hongya, Xiaoli Liu, Zhijian Wang, et al.. (2024). The synergistic effect of the atherogenic index of plasma and hyperuricemia on the prediction of coronary chronic total occlusion lesion: an observational cross-sectional study. Frontiers in Cardiovascular Medicine. 11. 1437096–1437096. 1 indexed citations

Ma, Xiaoteng, Yan Sun, Yujing Cheng, et al.. (2024). The effect of hsCRP on TyG index-associated cardiovascular risk in patients with acute coronary syndrome undergoing PCI. Scientific Reports. 14(1). 18083–18083. 7 indexed citations

10.

Wang, Yufei, et al.. (2024). Value of Absolute Eosinophil Count in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. International Journal of General Medicine. Volume 17. 1025–1038.

11.

Guo, Congting, Xiaoteng Ma, Fei Gao, & Yuxuan Guo. (2023). Off-target effects in CRISPR/Cas9 gene editing. Frontiers in Bioengineering and Biotechnology. 11. 1143157–1143157. 285 indexed citations breakdown →

12.

Yang, Zhiqiang, Qiaoyu Shao, Yufei Wang, et al.. (2023). Comparison of percutaneous coronary intervention of native coronary artery versus bypass graft in patients with prior coronary artery bypass grafting. Journal of Thoracic Disease. 15(10). 5371–5385. 1 indexed citations

13.

Wang, Zhijian, Fei Gao, Lixia Yang, et al.. (2022). Effect of Presence versus Absence of Hypertension on Admission Heart Rate-Associated Cardiovascular Risk in Patients with Acute Coronary Syndrome. International Journal of Hypertension. 2022. 1–7. 5 indexed citations

14.

Shi, Dongmei, Lixia Yang, Meng Xie, et al.. (2022). Relation of Monocyte Number to Progression of Aortic Stenosis. The American Journal of Cardiology. 171. 122–126. 2 indexed citations

15.

Gao, Fei, et al.. (2021). Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography. Lipids in Health and Disease. 20(1). 106–106. 27 indexed citations

16.

Shao, Qiaoyu, et al.. (2021). Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 21(1). 574–574. 1 indexed citations

17.

Ma, Xiaoteng, Lisha Dong, Qiaoyu Shao, et al.. (2020). Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome. Cardiovascular Diabetology. 19(1). 31–31. 152 indexed citations

18.

Ma, Xiaoteng, Qiaoyu Shao, Lisha Dong, et al.. (2020). Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Medicine. 99(30). e21321–e21321. 9 indexed citations

19.

He, Yuanzhou, Nian Sun, Wensheng Zhang, et al.. (2019). Ewing sarcoma/primitive neuro-ectodermal tumor of the urogenital system in children: a retrospective observational case series. Journal of Pediatric Urology. 15(5). 556.e1–556.e7. 5 indexed citations

20.

Dong, Li, et al.. (2011). Low-intensityanticoagulation therapy in the pregnant women with mechanical heart valves:a report with56 cases. 27(1). 8–10. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact